Published in Acta Histochem on April 01, 2008
Modulating molecular chaperones improves sensory fiber recovery and mitochondrial function in diabetic peripheral neuropathy. Exp Neurol (2012) 1.59
Dissociation of thermal hypoalgesia and epidermal denervation in streptozotocin-diabetic mice. Neurosci Lett (2008) 1.31
Advanced glycation end products in extracellular matrix proteins contribute to the failure of sensory nerve regeneration in diabetes. Diabetes (2009) 1.24
Diet-induced obesity in Sprague-Dawley rats causes microvascular and neural dysfunction. Diabetes Metab Res Rev (2010) 1.21
Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice. Diabetes (2011) 1.10
Phenotypic changes in diabetic neuropathy induced by a high-fat diet in diabetic C57BL/6 mice. Exp Diabetes Res (2011) 1.06
Repeated monitoring of corneal nerves by confocal microscopy as an index of peripheral neuropathy in type-1 diabetic rodents and the effects of topical insulin. J Peripher Nerv Syst (2013) 1.04
Effect of treatment of high fat fed/low dose streptozotocin-diabetic rats with Ilepatril on vascular and neural complications. Eur J Pharmacol (2011) 1.01
Diabetic peripheral neuropathy: should a chaperone accompany our therapeutic approach? Pharmacol Rev (2012) 0.99
Peripheral neuropathy in rats exposed to dichloroacetate. J Neuropathol Exp Neurol (2009) 0.97
Role of the effect of inhibition of neutral endopeptidase on vascular and neural complications in streptozotocin-induced diabetic rats. Eur J Pharmacol (2010) 0.95
Effect of inhibition of angiotensin converting enzyme and/or neutral endopeptidase on vascular and neural complications in high fat fed/low dose streptozotocin-diabetic rats. Eur J Pharmacol (2011) 0.92
Neuroprotective effect of the glucagon-like peptide-1 receptor agonist, synthetic exendin-4, in streptozotocin-induced diabetic rats. Br J Pharmacol (2011) 0.91
Effect of Treatment of Sprague Dawley Rats with AVE7688, Enalapril, or Candoxatril on Diet-Induced Obesity. J Obes (2010) 0.89
Partial replacement with menhaden oil improves peripheral neuropathy in high-fat-fed low-dose streptozotocin type 2 diabetic rat. J Nutr Metab (2012) 0.89
Vasopeptidase inhibitor ilepatril (AVE7688) prevents obesity- and diabetes-induced neuropathy in C57Bl/6J mice. Neuropharmacology (2010) 0.87
A clinical and neuropathological study of Chinese patients with diabetic peripheral neuropathy. PLoS One (2014) 0.86
Anti-inflammatory mesenchymal stem cells (MSC2) attenuate symptoms of painful diabetic peripheral neuropathy. Stem Cells Transl Med (2012) 0.82
Treatment of streptozotocin-induced diabetic rats with alogliptin: effect on vascular and neural complications. Exp Diabetes Res (2011) 0.81
Skin Matters: A Review of Topical Treatments for Chronic Pain. Part One: Skin Physiology and Delivery Systems. Pain Ther (2015) 0.81
Therapeutic Benefit of Extended Thymosin β4 Treatment Is Independent of Blood Glucose Level in Mice with Diabetic Peripheral Neuropathy. J Diabetes Res (2015) 0.80
Effect of Inhibition of Angiotensin-Converting Enzyme and/or Neutral Endopeptidase on Neuropathy in High-Fat-Fed C57Bl/6J Mice. J Obes (2012) 0.80
Characterization of diabetic neuropathy in the Zucker diabetic Sprague-Dawley rat: a new animal model for type 2 diabetes. J Diabetes Res (2014) 0.79
Nerve-Langerhans cell interactions in diabetes and aging. Histol Histopathol (2012) 0.79
Matrix metalloproteinase-2 is downregulated in sciatic nerve by streptozotocin induced diabetes and/or treatment with minocycline: Implications for nerve regeneration. Exp Neurol (2014) 0.78
Nociception at the diabetic foot, an uncharted territory. World J Diabetes (2015) 0.77
Angioblast Derived from ES Cells Construct Blood Vessels and Ameliorate Diabetic Polyneuropathy in Mice. J Diabetes Res (2015) 0.76
Evaluation of dermal myelinated nerve fibers in diabetes mellitus. J Peripher Nerv Syst (2013) 0.76
Peripheral Neuropathy in Mouse Models of Diabetes. Curr Protoc Mouse Biol (2016) 0.76
Selective antagonism of muscarinic receptors is neuroprotective in peripheral neuropathy. J Clin Invest (2017) 0.75
NON-INVASIVE EVALUATION OF NERVE CONDUCTION IN SMALL DIAMETER FIBERS IN THE RAT. Physiol J (2013) 0.75
Rat Models of Diet-Induced Obesity and High Fat/Low Dose Streptozotocin Type 2 Diabetes: Effect of Reversal of High Fat Diet Compared to Treatment with Enalapril or Menhaden Oil on Glucose Utilization and Neuropathic Endpoints. J Diabetes Res (2015) 0.75
Automated PGP9.5 immunofluorescence staining: a valuable tool in the assessment of small fiber neuropathy? BMC Res Notes (2016) 0.75
Quality of life in polyneuropathy: association with biomarkers of small fiber impairment. Health Qual Life Outcomes (2015) 0.75
The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature (1997) 30.59
The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science (1989) 3.84
The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology (2003) 3.60
Tackling pain at the source: new ideas about nociceptors. Neuron (1998) 3.50
Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch Neurol (1998) 3.39
Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes (2007) 2.95
Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients. Diabetologia (2003) 2.45
Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments. Brain (2004) 2.45
Quantitation of epidermal nerves in diabetic neuropathy. Neurology (1996) 2.12
Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies. Neurology (1999) 1.93
The expression of P2X3 purinoreceptors in sensory neurons: effects of axotomy and glial-derived neurotrophic factor. Mol Cell Neurosci (1998) 1.92
Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation. Pain (1999) 1.90
The innervation of human epidermis. J Neurol Sci (1993) 1.90
The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain (2004) 1.90
The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity. Diabetes (2006) 1.84
Erythropoietin both protects from and reverses experimental diabetic neuropathy. Proc Natl Acad Sci U S A (2004) 1.65
HSV-mediated gene transfer of vascular endothelial growth factor to dorsal root ganglia prevents diabetic neuropathy. Gene Ther (2005) 1.63
Painful sensory neuropathy: prospective evaluation using skin biopsy. Neurology (1999) 1.62
Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy. Neurology (2001) 1.60
Intraepidermal nerve fibers are indicators of small-fiber neuropathy in both diabetic and nondiabetic patients. Diabetes Care (2004) 1.58
Diminished neuropeptide levels contribute to the impaired cutaneous healing response associated with diabetes mellitus. J Surg Res (2002) 1.52
Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo. Brain Res (1993) 1.51
Differential expression of the capsaicin receptor TRPV1 and related novel receptors TRPV3, TRPV4 and TRPM8 in normal human tissues and changes in traumatic and diabetic neuropathy. BMC Neurol (2007) 1.51
Restorative effects of neurotrophin treatment on diabetes-induced cutaneous axon loss in mice. Exp Neurol (2003) 1.50
The relationship among pain, sensory loss, and small nerve fibers in diabetes. Diabetes Care (2006) 1.48
Reduced heat sensitivity and epidermal nerve fiber immunostaining following single applications of a high-concentration capsaicin patch. Pain (2004) 1.40
Intraepidermal nerve fiber density in rat foot pad: neuropathologic-neurophysiologic correlation. J Peripher Nerv Syst (2005) 1.37
Remote neurotrophic support of epidermal nerve fibres in experimental diabetes. Diabetologia (2006) 1.35
Classification, differential diagnosis, and staging of diabetic peripheral neuropathy. Diabetes (1997) 1.34
Intraepidermal nerve fiber density as a marker of early diabetic neuropathy. Muscle Nerve (2007) 1.30
Intraepidermal nerve fiber density in patients with painful sensory neuropathy. Neurology (1997) 1.27
The reliability of skin biopsy with measurement of intraepidermal nerve fiber density. J Neurol Sci (2004) 1.26
Experimental diabetic neuropathy with spontaneous recovery: is there irreparable damage? Diabetes (2005) 1.25
PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy. Free Radic Biol Med (2007) 1.22
Nitrosative stress and peripheral diabetic neuropathy in leptin-deficient (ob/ob) mice. Exp Neurol (2007) 1.21
Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis. Neuroscience (2006) 1.17
Increased capsaicin receptor TRPV1 in skin nerve fibres and related vanilloid receptors TRPV3 and TRPV4 in keratinocytes in human breast pain. BMC Womens Health (2005) 1.17
Small fiber neuropathy is associated with the metabolic syndrome. Metab Syndr Relat Disord (2005) 1.14
Expression of capsaicin receptor immunoreactivity in human peripheral nervous system and in painful neuropathies. J Peripher Nerv Syst (2006) 1.12
Two immunohistochemically identified populations of calcitonin gene-related peptide (CGRP)-immunoreactive axons in human skin. Brain Res (1987) 1.11
Insulin and insulin-like growth factor I enhance regeneration in cultured adult rat sensory neurones. Brain Res (1993) 1.10
Differential hypertrophy and atrophy among all types of cutaneous innervation in the glabrous skin of the monkey hand during aging and naturally occurring type 2 diabetes. J Comp Neurol (2007) 1.10
Immunoreactivity of VR1 on epidermal keratinocyte of human skin. Biochem Biophys Res Commun (2001) 1.09
Neuropathological alterations in diabetic truncal neuropathy: evaluation by skin biopsy. J Neurol Neurosurg Psychiatry (1998) 1.07
Prolonged preservation of nerve function in diabetic neuropathy in mice by herpes simplex virus-mediated gene transfer. Diabetologia (2007) 1.05
Innervation and vasculature of human sweat glands: an immunohistochemistry-laser scanning confocal fluorescence microscopy study. J Neurosci (1994) 1.05
Tubule and neurofilament immunoreactivity in human hairy skin: markers for intraepidermal nerve fibers. Muscle Nerve (2004) 1.04
Cutaneous innervation in man visualized with protein gene product 9.5 (PGP 9.5) antibodies. Histochemistry (1989) 1.03
Color subtractive-computer-assisted image analysis for quantification of cutaneous nerves in a diabetic mouse model. J Histochem Cytochem (2001) 1.03
Protein gene product 9.5-immunoreactive nerve fibres and cells in human skin. Cell Tissue Res (1990) 1.02
Insulin as an in vivo growth factor. Exp Neurol (2004) 0.99
Tau gene expression in rat sensory neurons during development and regeneration. J Neurosci (1991) 0.97
A skin blister method to study epidermal nerves in peripheral nerve disease. Muscle Nerve (1999) 0.97
Sensory and autonomic innervation of non-hairy and hairy human skin. An immunohistochemical study. Cell Tissue Res (1986) 0.96
New insights into diabetic polyneuropathy. JAMA (2003) 0.95
Noninvasive monitoring of diabetes-induced cutaneous nerve fiber loss and hypoalgesia in thy1-YFP transgenic mice. Diabetes (2005) 0.95
Immunohistochemical measurements of nerves and neuropeptides in diabetic skin: relationship to tests of neurological function. Diabetologia (1992) 0.92
Evaluation of diabetic neuropathy through the quantitation of cutaneous nerves. J Neurol Sci (2000) 0.91
Early increase in CGRP- and VIP-immunoreactive nerves in the skin of streptozotocin-induced diabetic rats. Histochemistry (1990) 0.90
Severe depletion of intraepidermal nerve fibers in skin biopsies of pancreas transplant recipients. Transplant Proc (2005) 0.89
Testosterone derivatives are neuroprotective agents in experimental diabetic neuropathy. Cell Mol Life Sci (2007) 0.89
Heavily pigmented melanocytic neoplasms: comparison of two melanin-bleaching techniques and subsequent immunohistochemical staining. Br J Biomed Sci (1999) 0.89
Depletion of cutaneous nerves and neuropeptides in diabetes mellitus: an immunocytochemical study. Diabetologia (1989) 0.88
Opportunities afforded by the study of unmyelinated nerves in skin and other organs. Muscle Nerve (2004) 0.87
A quantitative method for the assessment of intraepidermal nerve fibers in small-fiber neuropathy. J Neurol (2005) 0.87
Nerve fibre studies in skin biopsies in peripheral neuropathies. I. Immunohistochemical analysis of neuropeptides in diabetes mellitus. J Neurol Sci (1989) 0.87
Blood sugar and diabetic complications. N Engl J Med (1978) 0.80
Localization of unmyelinated axons in rat skin and mucocutaneous tissue utilizing the isolectin GS-I-B4. Somatosens Mot Res (1997) 0.80
Tactile hyperesthesia, altered epidermal innervation and plantar nerve injury in the hindfeet of rats housed on wire grates. Brain Res (1998) 0.79
Expression of PGP9.5 on Langerhans' cells and their precursors. Acta Derm Venereol (2000) 0.78
Development, differentiation, and proliferation of epidermal Langerhans cells in rat ontogeny studied by a novel monoclonal antibody against epidermal Langerhans cells, RED-1. J Leukoc Biol (1992) 0.78
Activation of p38 mitogen-activated protein kinase in spinal microglia is a critical link in inflammation-induced spinal pain processing. J Neurochem (2003) 2.42
MTM1 mutation associated with X-linked myotubular myopathy in Labrador Retrievers. Proc Natl Acad Sci U S A (2010) 1.64
Insulin prevents depolarization of the mitochondrial inner membrane in sensory neurons of type 1 diabetic rats in the presence of sustained hyperglycemia. Diabetes (2003) 1.50
Nesprin 1 is critical for nuclear positioning and anchorage. Hum Mol Genet (2009) 1.48
NF-M is an essential target for the myelin-directed "outside-in" signaling cascade that mediates radial axonal growth. J Cell Biol (2003) 1.41
Reduced heat sensitivity and epidermal nerve fiber immunostaining following single applications of a high-concentration capsaicin patch. Pain (2004) 1.40
Dissociation of thermal hypoalgesia and epidermal denervation in streptozotocin-diabetic mice. Neurosci Lett (2008) 1.31
Diet-induced obesity in Sprague-Dawley rats causes microvascular and neural dysfunction. Diabetes Metab Res Rev (2010) 1.21
Allodynia and hyperalgesia in diabetic rats are mediated by GABA and depletion of spinal potassium-chloride co-transporters. Pain (2008) 1.18
The MMP-9/TIMP-1 axis controls the status of differentiation and function of myelin-forming Schwann cells in nerve regeneration. PLoS One (2012) 1.18
Mitochondrial respiratory chain dysfunction in dorsal root ganglia of streptozotocin-induced diabetic rats and its correction by insulin treatment. Diabetes (2010) 1.17
Therapeutic efficacy of sonic hedgehog protein in experimental diabetic neuropathy. J Clin Invest (2003) 1.14
The roles of streptozotocin neurotoxicity and neutral endopeptidase in murine experimental diabetic neuropathy. Exp Diabetes Res (2010) 1.13
Gene replacement in mice reveals that the heavily phosphorylated tail of neurofilament heavy subunit does not affect axonal caliber or the transit of cargoes in slow axonal transport. J Cell Biol (2002) 1.11
Memantine protects neurons from shrinkage in the lateral geniculate nucleus in experimental glaucoma. Arch Ophthalmol (2006) 1.08
The ER-bound RING finger protein 5 (RNF5/RMA1) causes degenerative myopathy in transgenic mice and is deregulated in inclusion body myositis. PLoS One (2008) 1.05
Repeated monitoring of corneal nerves by confocal microscopy as an index of peripheral neuropathy in type-1 diabetic rodents and the effects of topical insulin. J Peripher Nerv Syst (2013) 1.04
Phosphorylation of highly conserved neurofilament medium KSP repeats is not required for myelin-dependent radial axonal growth. J Neurosci (2009) 1.04
Pathogenesis of spinally mediated hyperalgesia in diabetes. Diabetes (2007) 1.03
The pathological interaction between diabetes and presymptomatic Alzheimer's disease. Neurobiol Aging (2008) 1.01
Ciliary neurotrophic factor improves nerve conduction and ameliorates regeneration deficits in diabetic rats. Diabetes (2004) 0.99
Mitochondrion as a novel site of dichloroacetate biotransformation by glutathione transferase zeta 1. J Pharmacol Exp Ther (2010) 0.98
The blood-nerve barrier: structure and functional significance. Methods Mol Biol (2011) 0.98
Peripheral neuropathy in rats exposed to dichloroacetate. J Neuropathol Exp Neurol (2009) 0.97
Secretion of amyloidogenic gelsolin progressively compromises protein homeostasis leading to the intracellular aggregation of proteins. Proc Natl Acad Sci U S A (2009) 0.96
B vitamins alleviate indices of neuropathic pain in diabetic rats. Eur J Pharmacol (2009) 0.95
Degenerative myelopathy associated with a missense mutation in the superoxide dismutase 1 (SOD1) gene progresses to peripheral neuropathy in Pembroke Welsh corgis and boxers. J Neurol Sci (2012) 0.95
Endoneurial microvascular pathology in feline diabetic neuropathy. Microvasc Res (2007) 0.94
Neurological disease in wild loggerhead sea turtles Caretta caretta. Dis Aquat Organ (2006) 0.90
Non-pathogenic protein aggregates in skeletal muscle in MLF1 transgenic mice. J Neurol Sci (2007) 0.90
Impaired formalin-evoked changes of spinal amino acid levels in diabetic rats. Brain Res (2006) 0.89
Abnormal calcium homeostasis in peripheral neuropathies. Cell Calcium (2009) 0.88
Muscle pathology without severe nerve pathology in a new mouse model of Charcot-Marie-Tooth disease type 2E. Hum Mol Genet (2011) 0.88
Ciliary neurotrophic factor activates NF-κB to enhance mitochondrial bioenergetics and prevent neuropathy in sensory neurons of streptozotocin-induced diabetic rodents. Neuropharmacology (2012) 0.87
Elevated spinal cyclooxygenase and prostaglandin release during hyperalgesia in diabetic rats. Diabetes (2002) 0.87
Neurotrophin-3 prevents the proximal accumulation of neurofilament proteins in sensory neurons of streptozocin-induced diabetic rats. Diabetes (2003) 0.86
Electrodiagnostic testing and histopathologic changes confirm peripheral nervous system myelin abnormalities in the feline model of niemann-pick disease type C. J Neuropathol Exp Neurol (2013) 0.85
Animal models of diabetes-induced neuropathic pain. Curr Top Behav Neurosci (2014) 0.85
Myofibrillar myopathy with desmin accumulation in a young Australian Shepherd dog. Neuromuscul Disord (2004) 0.84
Considerations for quantification of lipids in nerve tissue using matrix-assisted laser desorption/ionization mass spectrometric imaging. Rapid Commun Mass Spectrom (2011) 0.84
MALDI-linear ion trap microprobe MS/MS studies of the effects of dichloroacetate on lipid content of nerve tissue. Anal Chem (2007) 0.84
Hypertension-induced peripheral neuropathy and the combined effects of hypertension and diabetes on nerve structure and function in rats. Acta Neuropathol (2012) 0.83
Ciliary neurotrophic factor reverses aberrant mitochondrial bioenergetics through the JAK/STAT pathway in cultured sensory neurons derived from streptozotocin-induced diabetic rodents. Cell Mol Neurobiol (2014) 0.82
Therapeutic efficacy of prosaposin-derived peptide on different models of allodynia. Pain (2006) 0.82
Protection of sensory function in diabetic rats by Neotrofin. Eur J Pharmacol (2006) 0.82
Treating small fiber neuropathy by topical application of a small molecule modulator of ligand-induced GFRα/RET receptor signaling. Proc Natl Acad Sci U S A (2014) 0.82
Novel sites of aldose reductase immunolocalization in normal and streptozotocin-diabetic rats. J Peripher Nerv Syst (2006) 0.82
Demyelinating polyneuropathy with focally folded myelin sheaths in a family of Miniature Schnauzer dogs. J Neurol Sci (2008) 0.81
A novel nitric oxide scavenger in combination with cyclosporine A ameliorates experimental autoimmune encephalomyelitis progression in mice. J Neuroimmunol (2003) 0.81
Inherited polyneuropathy in Leonberger dogs: a mixed or intermediate form of Charcot-Marie-Tooth disease? Muscle Nerve (2003) 0.81
The α5 subunit containing GABAA receptors contribute to chronic pain. Pain (2016) 0.80
Impaired prosaposin secretion during nerve regeneration in diabetic rats and protection of nerve regeneration by a prosaposin-derived peptide. J Neuropathol Exp Neurol (2008) 0.79
Elevated lipid peroxidation and DNA oxidation in nerve from diabetic rats: effects of aldose reductase inhibition, insulin, and neurotrophic factors. Metabolism (2008) 0.78
Expansion of neurofilament medium C terminus increases axonal diameter independent of increases in conduction velocity or myelin thickness. J Neurosci (2012) 0.78
Functional magnetic resonance imaging of the spinal cord during sensory stimulation in diabetic rats. J Magn Reson Imaging (2009) 0.77
Myopathy with tubulin-reactive inclusions in two cats. Acta Neuropathol (2007) 0.77
Guaifenesin derivatives promote neurite outgrowth and protect diabetic mice from neuropathy. J Med Chem (2013) 0.77
Vacuolar myopathy in a dog resembling human sporadic inclusion body myositis. Acta Neuropathol (2009) 0.76
Selective antagonism of muscarinic receptors is neuroprotective in peripheral neuropathy. J Clin Invest (2017) 0.75
Central action of prosaptide TX14(A) against gp120-induced allodynia in rats. Eur J Pain (2007) 0.75
Congenital myopathy with abundant nemaline rods in a cat. Neuromuscul Disord (2006) 0.75